Original Research

Published on 24 Nov 2021

The Role of Gut Microbiota and Microbiota-Related Serum Metabolites in the Progression of Diabetic Kidney Disease

in Renal Pharmacology

Qing Zhang
Yanmei Zhang
Lu Zeng
Guowei Chen
La Zhang
Meifang Liu
Hongqin Sheng
Xiaoxuan Hu
Jingxu Su
Duo Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2021.757508

7,611 views
38 citations

Systematic Review

Published on 19 Nov 2021

Effect of Angiotensin–Neprilysin Versus Renin–Angiotensin System Inhibition on Renal Outcomes: A Systematic Review and Meta-Analysis

in Renal Pharmacology

Ying Xu
Yang Chen
Jia Wei Zhao
Chao Li
Amanda Y Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2021.604017

12,785 views
8 citations

Mini Review

Published on 16 Nov 2021

Mini-Review: GSDME-Mediated Pyroptosis in Diabetic Nephropathy

in Renal Pharmacology

Wen Li
Jing Sun
Xiaoxi Zhou
Yue Lu
Wenpeng Cui
Lining Miao

Frontiers in Pharmacology

doi 10.3389/fphar.2021.780790

11,109 views
27 citations

Original Research

Published on 15 Nov 2021

Uncovering Bupi Yishen Formula Pharmacological Mechanisms Against Chronic Kidney Disease by Network Pharmacology and Experimental Validation

in Renal Pharmacology

Difei Zhang
Bingran Liu
Xina Jie
Jiankun Deng
Zhaoyu Lu
Fuhua Lu
Xusheng Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2021.761572

4,635 views
4 citations

Original Research

Published on 11 Nov 2021

Farrerol Ameliorated Cisplatin-Induced Chronic Kidney Disease Through Mitophagy Induction via Nrf2/PINK1 Pathway

in Renal Pharmacology

Ning Ma
Zhentong wei
Jianqiang Hu
Wenjing Gu
Xinxin Ci

Frontiers in Pharmacology

doi 10.3389/fphar.2021.768700

8,570 views
28 citations

Review

Published on 04 Nov 2021

New Insights Into the Effects of Individual Chinese Herbal Medicines on Chronic Kidney Disease

in Renal Pharmacology

Minghai Shao
Chaoyang Ye
George Bayliss
Shougang Zhuang

Frontiers in Pharmacology

doi 10.3389/fphar.2021.774414

8,654 views
34 citations

Mini Review

Published on 02 Nov 2021

Augmented Renal Clearance: What Have We Known and What Will We Do?

in Renal Pharmacology

Yifan Luo
Yidan Wang
Yue Ma
Puxiu Wang
Jian Zhong
Yang Chu

Frontiers in Pharmacology

doi 10.3389/fphar.2021.723731

12,257 views
19 citations

Review

Published on 28 Oct 2021

Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease

in Renal Pharmacology

Daiji Kawanami
Yuichi Takashi
Yoshimi Muta
Naoki Oda
Dai Nagata
Hiroyuki Takahashi
Makito Tanabe

Frontiers in Pharmacology

doi 10.3389/fphar.2021.754239

13,425 views
29 citations

Review

Published on 21 Oct 2021

Sodium–Glucose Cotransporter 2 Inhibitors Work as a “Regulator” of Autophagic Activity in Overnutrition Diseases

in Renal Pharmacology

Kazuhiko Fukushima
Shinji Kitamura
Kenji Tsuji
Jun Wada

Frontiers in Pharmacology

doi 10.3389/fphar.2021.761842

6,106 views
20 citations

Original Research

Published on 18 Oct 2021

Effect of Mahuang Fuzi and Shenzhuo Decoction on Idiopathic Membranous Nephropathy: A Multicenter, Nonrandomized, Single-Arm Clinical Trial

in Renal Pharmacology

Zhaocheng Dong
Haoran Dai
Yu Gao
Hanxue Jiang
Meiqi Liu
Fei Liu
Wenbin Liu
Zhendong Feng
Xiaoyan Zhang
Aijie Ren

Frontiers in Pharmacology

doi 10.3389/fphar.2021.724744

3,356 views
11 citations

Original Research

Published on 12 Oct 2021

Tongluo Yishen Decoction Ameliorates Renal Fibrosis via Regulating Mitochondrial Dysfunction Induced by Oxidative Stress in Unilateral Ureteral Obstruction Rats

in Renal Pharmacology

Qi Jia
Lin Han
Xiaoyu Zhang
Wenning Yang
Yushan Gao
Yifan Shen
Bing Li
Shuyan Wang
Mingzhen Qin
Scott Lowe

Frontiers in Pharmacology

doi 10.3389/fphar.2021.762756

5,513 views
17 citations

Original Research

Published on 12 Oct 2021

Dapagliflozin Ameliorates Diabetic Kidney Disease via Upregulating Crry and Alleviating Complement Over-activation in db/db Mice

in Renal Pharmacology

Dong-Yuan Chang
Xiao-Qian Li
Min Chen
Ming-Hui Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2021.729334

5,773 views
19 citations

Mini Review

Published on 11 Oct 2021

Carbon Monoxide in Pancreatic Islet Transplantation: A New Therapeutic Alternative to Patients With Severe Type 1 Diabetes Mellitus

in Renal Pharmacology

George J. Dugbartey

Frontiers in Pharmacology

doi 10.3389/fphar.2021.750816

2,545 views
6 citations

Brief Research Report

Published on 07 Oct 2021

Tacrolimus Intrapatient Variability After Switching From Immediate or Prolonged-Release to Extended-Release Formulation, After an Organ Transplantation

in Renal Pharmacology

Arnaud Del Bello
Clotilde Gaible
Nathalie Longlune
Anne-Laure Hebral
Laure Esposito
Peggy Gandia
Nassim Kamar

Frontiers in Pharmacology

doi 10.3389/fphar.2021.602764

4,084 views
6 citations

Original Research

Published on 06 Oct 2021

Astragalus Polysaccharide Reduces Blood Pressure, Renal Damage, and Dysfunction Through the TGF-β1-ILK Pathway

in Renal Pharmacology

Wei Zheng
Tao Huang
Qi-Zhen Tang
Shi Li
Jie Qin
Feng Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2021.706617

6,560 views
16 citations

Original Research

Published on 06 Oct 2021

Case Report: Subtherapeutic Vancomycin and Meropenem Concentrations due to Augmented Renal Clearance in a Patient With Intracranial Infection Caused by Streptococcus intermedius

in Renal Pharmacology

Marcus Fransson
Anders Helldén
Åse Östholm Balkhed
Dženeta Nezirević Dernroth
Maria Ha
Mats Haglund
Peter Milos
Håkan Hanberger
Bertil Kågedal

Frontiers in Pharmacology

doi 10.3389/fphar.2021.728075

3,521 views
11 citations

Navigation group

Articles

The Role of Gut Microbiota and Microbiota-Related Serum Metabolites in the Progression of Diabetic Kidney Disease

Effect of Angiotensin–Neprilysin Versus Renin–Angiotensin System Inhibition on Renal Outcomes: A Systematic Review and Meta-Analysis

Mini-Review: GSDME-Mediated Pyroptosis in Diabetic Nephropathy

Uncovering Bupi Yishen Formula Pharmacological Mechanisms Against Chronic Kidney Disease by Network Pharmacology and Experimental Validation

Farrerol Ameliorated Cisplatin-Induced Chronic Kidney Disease Through Mitophagy Induction via Nrf2/PINK1 Pathway

New Insights Into the Effects of Individual Chinese Herbal Medicines on Chronic Kidney Disease

Augmented Renal Clearance: What Have We Known and What Will We Do?

Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease

Sodium–Glucose Cotransporter 2 Inhibitors Work as a “Regulator” of Autophagic Activity in Overnutrition Diseases

Effect of Mahuang Fuzi and Shenzhuo Decoction on Idiopathic Membranous Nephropathy: A Multicenter, Nonrandomized, Single-Arm Clinical Trial

Tongluo Yishen Decoction Ameliorates Renal Fibrosis via Regulating Mitochondrial Dysfunction Induced by Oxidative Stress in Unilateral Ureteral Obstruction Rats

Dapagliflozin Ameliorates Diabetic Kidney Disease via Upregulating Crry and Alleviating Complement Over-activation in db/db Mice

Carbon Monoxide in Pancreatic Islet Transplantation: A New Therapeutic Alternative to Patients With Severe Type 1 Diabetes Mellitus

Tacrolimus Intrapatient Variability After Switching From Immediate or Prolonged-Release to Extended-Release Formulation, After an Organ Transplantation

Astragalus Polysaccharide Reduces Blood Pressure, Renal Damage, and Dysfunction Through the TGF-β1-ILK Pathway

Case Report: Subtherapeutic Vancomycin and Meropenem Concentrations due to Augmented Renal Clearance in a Patient With Intracranial Infection Caused by Streptococcus intermedius